From the research point of view, although several details are known regarding the molecular mechanism of MDK’s action in general, little is known regarding the specific pathways that are being activated in HCC, as most studies are focusing on its evaluation as a diagnostic biomarker. Here, MDK is linked to hepatocellular carcinoma.